RANDOMISED DOUBLE-BLIND PHASE III TRIAL OF CEDIRANIB (AZD 2171) IN RELAPSED PLATINUM SENSITIVE OVARIAN CANCER: RESULTS OF THE ICON6 TRIAL.

被引：0
|
作者：
Raja, F. A. [1 ,2 ]
Perren, T. J. [3 ]
Embleton, A. [4 ]
Rustin, G. J. S. [5 ]
Jayson, G. [6 ]
Swart, A. M. [4 ]
Vaughan, M. [7 ]
Hirte, H. [8 ]
Stark, D. P. [9 ]
Ledermann, J. A. [1 ,2 ]
机构：
[1] Canc Res UK, London, England
[2] UCL Canc Inst, UCL Canc Trials Ctr, London, England
[3] St James Univ Hosp, Dept Oncol, Leeds LS9 7TF, W Yorkshire, England
[4] MRC, Clin Trials Unit, London, England
[5] Mt Vernon Hosp, Dept Oncol, Northwood HA6 2RN, Middx, England
[6] Christie Hosp, Dept Oncol, Manchester, Lancs, England
[7] Christchurch Hosp, Christchurch, New Zealand
[8] Hamilton Reg Canc Ctr, Hamilton, ON L8V 1C3, Canada
[9] St James Univ Hosp, Leeds LS9 7TF, W Yorkshire, England
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2013年 / 23卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A randomized, double-blind phase 3 trial of maintenance therapy with niraparib vs placebo in patients with platinum-sensitive recurrent ovarian cancer (ENGOT-OV16/NOVA trial)
    Mirza, M. R.
    Monk, B. J.
    Oza, A.
    Mahner, S.
    Redondo, A.
    Fabbro, M.
    Ledermann, J.
    Lorusso, D.
    Vergote, I. B.
    Rosengarten, O.
    Berek, J.
    Herrstedt, J.
    Tinker, A. V.
    Dubois, A.
    Gonzalez Martin, A.
    Follana, P.
    Benigno, B.
    Rimel, B. J.
    Agarwal, S.
    Matulonis, U.
    ANNALS OF ONCOLOGY, 2016, 27
  • [42] Nivolumab versus placebo in patients with relapsed malignant mesothelioma (CONFIRM): a multicentre, double-blind, randomised, phase 3 trial
    Fennell, Dean A.
    Ewings, Sean
    Ottensmeier, Christian
    Califano, Raffaele
    Hanna, Gerard G.
    Hill, Kayleigh
    Danson, Sarah
    Steele, Nicola
    Nye, Mavis
    Johnson, Lucy
    Lord, Joanne
    Middleton, Calley
    Szlosarek, Peter
    Chan, Sam
    Gaba, Aarti
    Darlison, Liz
    Wells-Jordan, Peter
    Richards, Cathy
    Poile, Charlotte
    Lester, Jason F.
    Griffiths, Gareth
    LANCET ONCOLOGY, 2021, 22 (11): : 1530 - 1540
  • [43] Randomised trial of paclitaxel in combination with platinum chemotherapy versus platinum-based chemotherapy in the treatment of relapsed ovarian cancer (ICON4/OVAR 2.2)
    Ledermann, JA
    BRITISH JOURNAL OF CANCER, 2003, 88 : S9 - S9
  • [44] Glutathione reduces the toxicity and improves quality of life of women diagnosed with ovarian cancer treated with cisplatin: Results of a double-blind, randomised trial
    Smyth, JF
    Bowman, A
    Perren, T
    Wilkinson, P
    Prescott, RJ
    Quinn, KJ
    Tedeschi, M
    ANNALS OF ONCOLOGY, 1997, 8 (06) : 569 - 573
  • [45] Efficacy and safety of meloxicam in the treatment of osteoarthritis (OA): Results of a phase III double blind, placebo controlled trial.
    Yocum, DE
    Hall, DB
    Roszko, PJ
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S147 - S147
  • [46] Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial
    Kuse, Ernst-Ruediger
    Chetchotisakd, Ploenchan
    da Cunha, Clovis Arns
    Ruhnke, Markus
    Barrios, Carlos
    Raghunadharao, Digumarti
    Sekhon, Jagdev Singh
    Freire, Antonio
    Ramasubramanian, Venkatasubramanian
    Demeyer, Ignace
    Nucci, Marcio
    Leelarasamee, Amorn
    Jacobs, Frederique
    Decruyenaere, Johan
    Pittet, Didier
    Ullmann, Andrew J.
    Ostrosky-Zeichner, Luis
    Lortholary, Olivier
    Koblinger, Sonja
    Diekmann-Berndt, Heike
    Cornely, Oliver A.
    LANCET, 2007, 369 (9572): : 1519 - 1527
  • [47] Vandetanib in locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 2 trial
    Leboulleux, Sophie
    Bastholt, Lars
    Krause, Thomas
    de la Fouchardiere, Christelle
    Tennvall, Jan
    Awada, Ahmad
    Manuel Gomez, Jose
    Bonichon, Francoise
    Leenhardt, Laurence
    Soufflet, Christine
    Licour, Muriel
    Schlumberger, Martin J.
    LANCET ONCOLOGY, 2012, 13 (09): : 897 - 905
  • [48] OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
    Aghajanian, Carol
    Blank, Stephanie V.
    Goff, Barbara A.
    Judson, Patricia L.
    Teneriello, Michael G.
    Husain, Amreen
    Sovak, Mika A.
    Yi, Jing
    Nycum, Lawrence R.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (17) : 2039 - 2045
  • [49] Effect of intraperitoneal ropivacaine during and after cytoreductive surgery on time-interval to adjuvant chemotherapy in advanced ovarian cancer: a randomised, double-blind phase III trial
    Hasselgren, Emma
    Groes-Kofoed, Nina
    Falconer, Henrik
    Bjorne, Hakan
    Zach, Diana
    Hunde, Daniel
    Johansson, Hemming
    Asp, Mihaela
    Kannisto, Paivi
    Gupta, Anil
    Salehi, Sahar
    BRITISH JOURNAL OF ANAESTHESIA, 2025, 134 (03) : 662 - 670
  • [50] Chemotherapy vs tamoxifen in platinum-resistant ovarian cancer: a phase III, randomised, multicentre trial (Ovaresist)
    Kristina Lindemann
    Emma Gibbs
    Elisabeth Åvall-Lundqvist
    Rene dePont Christensen
    Kathrine Woie
    Marten Kalling
    Annika Auranen
    Seija Grenman
    Thomas Hoegberg
    Per Rosenberg
    Tone Skeie-Jensen
    Elisabet Hjerpe
    Anne Dørum
    Val Gebski
    Gunnar Kristensen
    British Journal of Cancer, 2017, 116 : 455 - 463
12345